SIC
PFE icon

SFE Investment Counsel’s Pfizer PFE Stock Holding History

SFE Investment Counsel’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.57M Buy
91,555
+5,010
+6% +$133K 0.41% 74
2025
Q4 		$2.15M Buy
86,545
+16,245
+23% +$410K 0.33% 74
2025
Q3 		$1.79M Sell
70,300
-4,930
-7% -$122K 0.29% 76
2025
Q2 		$1.82M Buy
75,230
+3,812
+5% +$88.9K 0.32% 74
2025
Q1 		$1.81M Buy
71,418
+11,088
+18% +$290K 0.36% 75
2024
Q4 		$1.6M Sell
60,330
-28,735
-32% -$779K 0.34% 70
2024
Q3 		$2.58M Sell
89,065
-5,514
-6% -$161K 0.54% 59
2024
Q2 		$2.65M Sell
94,579
-7,295
-7% -$201K 0.59% 57
2024
Q1 		$2.83M Buy
101,874
+22,770
+29% +$632K 0.64% 57
2023
Q4 		$2.28M Sell
79,104
-48,165
-38% -$1.46M 0.59% 61
2023
Q3 		$4.22M Buy
127,269
+7,065
+6% +$250K 1.23% 32
2023
Q2 		$4.41M Buy
120,204
+4,545
+4% +$177K 1.25% 30
2023
Q1 		$4.52M Buy
115,659
+14,160
+14% +$612K 1.4% 24
2022
Q4 		$4.56M Sell
101,499
-2,286
-2% -$110K 1.42% 24
2022
Q3 		$4.54M Sell
103,785
-330
-0.3% -$16K 1.43% 22
2022
Q2 		$5.46M Buy
104,115
+815
+0.8% +$41.5K 1.63% 19
2022
Q1 		$5.35M Sell
103,300
-1,898
-2% -$98.5K 1.35% 25
2021
Q4 		$6.21M Sell
105,198
-4,220
-4% -$209K 1.6% 20
2021
Q3 		$4.71M Sell
109,418
-1,285
-1% -$56.9K 1.32% 29
2021
Q2 		$4.33M Buy
110,703
+9,590
+9% +$373K 1.19% 30
2021
Q1 		$3.66M Buy
101,113
+46,687
+86% +$1.66M 1.07% 36
2020
Q4 		$2M Buy
54,426
+11,473
+27% +$421K 0.64% 49
2020
Q3 		$1.5M Buy
42,953
+9,865
+30% +$346K 0.6% 51
2020
Q2 		$1.03M Buy
33,088
+7,133
+27% +$242K 0.45% 57
2020
Q1 		$804K Buy
25,955
+53
+0.2% +$1.81K 0.44% 61
2019
Q4 		$963K Sell
25,902
-2,725
-10% -$97.1K 0.39% 69
2019
Q3 		$976K Buy
28,627
+775
+3% +$28.2K 0.41% 68
2019
Q2 		$1.15M Hold
27,852
– – 0.49% 61
2019
Q1 		$1.12M Sell
27,852
-1,196
-4% -$47.9K 0.51% 58
2018
Q4 		$1.2M Sell
29,048
-12,049
-29% -$500K 0.62% 47
2018
Q3 		$1.72M Sell
41,097
-267
-0.6% -$10.3K 0.66% 46
2018
Q2 		$1.42M Sell
41,364
-302
-0.7% -$10.3K 0.59% 48
2018
Q1 		$1.4M Sell
41,666
-4,637
-10% -$159K 0.73% 40
2017
Q4 		$1.59M Sell
46,303
-248
-0.5% -$8.46K 0.64% 49
2017
Q3 		$1.58M Sell
46,551
-490
-1% -$15.7K 0.66% 49
2017
Q2 		$1.5M Sell
47,041
-6,834
-13% -$216K 0.61% 52
2017
Q1 		$1.75M Buy
53,875
+2,339
+5% +$73.7K 0.64% 45
2016
Q4 		$1.52M Buy
51,536
+42,644
+480% +$1.3M 0.59% 50
2016
Q3 		$297K Hold
8,892
– – 0.14% 84
2016
Q2 		$297K Hold
8,892
– – 0.14% 85
2016
Q1 		$250K Hold
8,892
– – 0.12% 90
2015
Q4 		$272K Sell
8,892
-1,202
-12% -$37.8K 0.13% 88
2015
Q3 		$301K Buy
10,094
+1,111
+12% +$35.6K 0.14% 86
2015
Q2 		$286K Buy
+8,983
New +$293K 0.12% 90

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

SFE Investment Counsel's PFE Position: Q1 2026 in Review

SFE Investment Counsel increased its Pfizer (PFE) stake by 5.8% in Q1 2026, buying an estimated $133K and bringing the position to 91,555 shares worth $2.57M. The position accounts for 0.41% of the portfolio, ranked #74.

SFE Investment Counsel first reported a position in PFE in Q2 2015 and has held it in 44 quarters since. The position peaked at $6.21M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • SFE Investment Counsel held 91,555 shares of Pfizer worth $2.57M as of Q1 2026.
  • SFE Investment Counsel bought 5,010 Pfizer shares in Q1 2026, an estimated $133K.
  • Pfizer made up 0.41% of SFE Investment Counsel's portfolio in Q1 2026, its #74 holding.
  • SFE Investment Counsel first reported a position in Pfizer in Q2 2015 and has held it in 44 quarters since.
  • SFE Investment Counsel's Pfizer position peaked at $6.21M in Q4 2021.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on SFE Investment Counsel's 13F filing for Q1 2026, filed 1 May 2026.